362 related articles for article (PubMed ID: 8615699)
1. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
Pemberton AD; Huntley JF; Miller HR
Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
[TBL] [Abstract][Full Text] [Related]
3. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
6. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
Fritz H
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
[TBL] [Abstract][Full Text] [Related]
7. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histamine release from human mast cells by natural chymase inhibitors.
He SH; Xie H; Zhang XJ; Wang XJ
Acta Pharmacol Sin; 2004 Jun; 25(6):822-6. PubMed ID: 15169639
[TBL] [Abstract][Full Text] [Related]
9. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient inhibition of human chymase by alpha(2)-macroglobulin.
Walter M; Sutton RM; Schechter NM
Arch Biochem Biophys; 1999 Aug; 368(2):276-84. PubMed ID: 10441378
[TBL] [Abstract][Full Text] [Related]
11. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
He S; Walls AF
Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
[TBL] [Abstract][Full Text] [Related]
12. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
Sayama S; Iozzo RV; Lazarus GS; Schechter NM
J Biol Chem; 1987 May; 262(14):6808-15. PubMed ID: 3553192
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
Addington AK; Johnson DA
Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
[TBL] [Abstract][Full Text] [Related]
14. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
Westin U; Polling A; Ljungkrantz I; Ohlsson K
Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
[TBL] [Abstract][Full Text] [Related]
15. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
16. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
17. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
Schechter NM; Sprows JL; Schoenberger OL; Lazarus GS; Cooperman BS; Rubin H
J Biol Chem; 1989 Dec; 264(35):21308-15. PubMed ID: 2592376
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Ying QL; Kemme M; Saunders D; Simon SR
Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
20. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
